Enclomiphene vs TRT: FDA Status, Cost and Trade-offs

Q: Is enclomiphene FDA-approved like testosterone?

No. Testosterone products are FDA-approved; enclomiphene is sold only as a compounded drug.

Enclomiphene vs TRT

The core difference is FDA approval: testosterone products are approved for men with low testosterone caused by primary or hypogonadotropic hypogonadism ^[1], while enclomiphene is not FDA-approved and is sold only as a compounded drug ^[2]. Generic testosterone cypionate costs about $20 to $31 per vial with a coupon ^[3]; Hims sells compounded enclomiphene from $99 a month on a 10-month prepaid plan ^[2].

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Quick answer

Testosterone has FDA labels, a large heart-safety trial and cheap generics. Enclomiphene has none of those: it is compounded, and we could not confirm trial results to cite. Clinics market it as an alternative to testosterone. If a prescriber suggests it, ask why an unapproved drug fits you better than an approved one.

Why this page is marked incomplete

Our research could not confirm published trial results, side-effect rates or an FDA statement for enclomiphene, including FDA's position on whether pharmacies may compound it. We show what is known and say plainly where the comparison has gaps.

Side by side

Enclomiphene vs testosterone replacement therapy
	Testosterone (TRT)	Enclomiphene
FDA status	FDA-approved ^[1]	Not FDA-approved; compounded ^[2]
Approved use	Low testosterone with primary or hypogonadotropic hypogonadism; not age-related low T ^[1]	None
Forms	Injection, gel, oral (Jatenzo, Kyzatrex, Tlando). Clinics also sell creams and pellets; ask whether yours is an FDA-approved product or compounded	Compounded product from telehealth and men's clinics
Dose	Set by each product's FDA label and your prescriber	No FDA label, so no approved dose
Key safety data	TRAVERSE: major heart events 7.0% vs 7.3%; more pulmonary embolism, atrial fibrillation and kidney injury ^[4]	Not confirmed in our research
Label warnings	Blood pressure warning class-wide (2025) ^[5]; gels boxed for secondary exposure ^[1]	No FDA label
Price, Oct 17, 2026	Generic cypionate about $20 to $31 per 1 mL vial with coupon ^[3]; TRT Nation program $99 a month ^[6]	Hims from $99 a month on a 10-month prepaid plan ^[2]
HSA/FSA	Depends on program	Not eligible at Hims ^[2]

The differences that matter

Review. Approved testosterone products went through FDA review and carry labels that FDA updated in 2025 ^[5]. Compounded enclomiphene skips FDA review for safety, effectiveness and quality.
Evidence. TRAVERSE randomized 5,204 men to testosterone gel or placebo ^[4]. We found no comparable enclomiphene trial in our research.
Diagnosis. Both should start with lab-confirmed low testosterone: the AUA uses two tests below 300 ng/dL plus symptoms or signs ^[7].
Cost structure. Generic testosterone is cheap per vial; enclomiphene's lowest published price ties you to a 10-month prepay ^[2].

Who each may fit

We cannot tell you which will work for you. Testosterone is the option with FDA approval for men whose low testosterone has a medical cause ^[1]. Enclomiphene is offered by programs such as TRT Nation, Maximus and Gameday ^[6]^[8]^[9]; ask the prescriber what evidence supports it for your situation and which pharmacy compounds it.

Switching between them

Enclomiphene has no FDA label, so there are no labeled switching instructions. Any change should come from your prescriber, with labs before and after. If you move to testosterone, the label now warns that it can raise blood pressure ^[5], so plan for blood pressure checks.

Safety note

The 2025 class-wide label change added a blood pressure warning to testosterone products that lacked one, after studies confirmed that testosterone raises blood pressure ^[5]. Testosterone gels carry a boxed warning because children who touched application sites have developed signs of male puberty ^[1]. In TRAVERSE, the testosterone group had more pulmonary embolism (0.9% vs 0.5%), atrial fibrillation and acute kidney injury ^[4]. Call 911 for chest pain, sudden shortness of breath or other emergencies.

Questions people ask

Is enclomiphene better than TRT?

We cannot say, because our research did not confirm trial results for enclomiphene. Testosterone is FDA-approved for hypogonadism with a medical cause ^[1] and has a 5,204-man heart-safety trial behind it ^[4]; enclomiphene is not FDA-approved ^[2].

Is enclomiphene cheaper than TRT?

Not on published prices. Generic testosterone cypionate costs about $20 to $31 per vial with a coupon ^[3], while Hims sells enclomiphene from $99 a month on a 10-month prepaid plan ^[2].

Is enclomiphene FDA-approved like testosterone?

No. Testosterone products are FDA-approved ^[1]; enclomiphene is sold only as a compounded drug ^[2].

Do I need labs for enclomiphene or TRT?

Yes for both. The AUA confirms low testosterone with two tests below 300 ng/dL plus symptoms or signs ^[7], and Hims requires an at-home lab kit before enclomiphene ^[2].

Can I switch from enclomiphene to TRT?

Only with your prescriber, since enclomiphene has no FDA label with switching instructions. Testosterone labels now include a blood pressure warning ^[5].